Cargando…
Calcifediol for Use in Treatment of Respiratory Disease
Calcifediol is the prohormone of the vitamin D endocrine system (VDES). It requires hydroxylation to move to 1,25(OH)2D3 or calcitriol, the active form that exerts its functions by activating the vitamin D receptor (VDR) that is expressed in many organs, including the lungs. Due to its rapid oral ab...
Autores principales: | Entrenas-Castillo, Marta, Salinero-González, Lourdes, Entrenas-Costa, Luis M., Andújar-Espinosa, Rubén |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231174/ https://www.ncbi.nlm.nih.gov/pubmed/35745177 http://dx.doi.org/10.3390/nu14122447 |
Ejemplares similares
-
Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2022) -
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
por: Entrenas Castillo, Marta, et al.
Publicado: (2020) -
Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases
por: Casado, Enrique, et al.
Publicado: (2023) -
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2021) -
Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2020)